Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma

BACKGROUND: Cancer mutations generate novel (neo-)peptides recognised by T cells, but the determinants of recognition are not well characterised. The difference in predicted class I major histocompatibility complex (MHC-I) binding affinity between wild-type and corresponding mutant peptides (differe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Oncol
Main Authors: Ghorani, E, Rosenthal, R, McGranahan, N, Reading, J L, Lynch, M, Peggs, K S, Swanton, C, Quezada, S A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Original articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834109/
https://ncbi.nlm.nih.gov/pubmed/29361136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx687
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares